Scott Tarriff, CEO at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 29,185 shares at $41.52 ($1.2M) on 2019-02-01, disclosed to the SEC on 2019-02-04.
Open-market sale of $1.2M EGRX by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| EGRX | SELL | 2023-05-18 | $300K | — | Filing → |
| EGRX | SELL | 2023-05-15 | $1.2M | — | Filing → |
| EGRX | SELL | 2019-04-03 | $2.5M | — | Filing → |